Does Knowledge of Treatment Assignment Affect Patient Report Of Symptoms, Function, and Health Status? An Evaluation Using Multiple Myeloma Trials

FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease

(2020) Bellinda L. King-Kallimanis et al.   QUALITY OF LIFE RESEARCH

Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials

(2019) Jessica K. Roydhouse et al.   JAMA Oncology

Medical foster home is less costly than traditional nursing home care

(2019) Cari Levy et al.   HEALTH SERVICES RESEARCH

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

(2019) Jorge E Cortes et al.   LANCET ONCOLOGY

US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017

(2019) Mallorie H Fiero et al.   LANCET ONCOLOGY

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial

(2018) James Larkin et al.   JOURNAL OF CLINICAL ONCOLOGY

OUP accepted manuscript

(2018)   JNCI-Journal of the National Cancer Institute

Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review

(2018) Madeline Pe et al.   LANCET ONCOLOGY

Trustworthiness of Patient-Reported Outcomes in Unblinded Cancer Clinical Trials

(2017) Thomas M. Atkinson et al.   JAMA Oncology

Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms

(2016) P. G. Kluetz et al.   CLINICAL CANCER RESEARCH

A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example

(2016) Raymond A. Harvey et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies

(2016) Matthew J. Page et al.   PLoS One

Estimation of causal effects of binary treatments in unconfounded studies

(2015) Roee Gutman et al.   STATISTICS IN MEDICINE

Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies

(2014) Asbjørn Hróbjartsson et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications

(2014) Segun Bello et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Different analyses estimate different parameters of the effect of erythropoietin stimulating agents on survival in end stage renal disease: a comparison of payment policy analysis, instrumental variables, and multiple imputation of potential outcomes

(2013) David D. Dore et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The Prevention and Treatment of Missing Data in Clinical Trials

(2012) Roderick J. Little et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Matching Methods for Causal Inference: A Review and a Look Forward

(2010) Elizabeth A. Stuart   STATISTICAL SCIENCE

The importance of allocation concealment and patient blinding in osteoarthritis trials: A meta-epidemiologic study

(2009) Eveline Nüesch et al.   ARTHRITIS AND RHEUMATISM

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

(2008) Lesley Wood et al.   BMJ-British Medical Journal